Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FLO | NOMD |
|---|---|---|
| Price | $5.84 | $11.00 |
| Change today | ▲ 1.74% | ▲ 0.27% |
| Market cap | $1.24B | $1.54B |
| Return, 3 months | -26.2% | -2.0% |
| Return, year to date | -42.8% | -7.9% |
| Return, 1 year | -49.4% | -8.4% |
| P/E (TTM) | 22.5 | 11.3 |
| P/B | 0.9 | 0.5 |
| P/E percentile vs own 5y | 38th | 27th |
| Dividend yield | 14.86% | 6.04% |
| Revenue growth (YoY, latest qtr) | -4.0% | -3.1% |
| Net profit growth (YoY) | -30.3% | -15.1% |
| Gross margin | 48.6% | 26.9% |
| Operating margin | 5.5% | 12.8% |
| Net margin | 1.1% | 4.2% |
| Return on equity | 4.0% | 4.9% |
| Analyst target vs. price | -5.8% | +31.8% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 42 | 52 |
| 30-day volatility | 27.2% | 24.5% |
| Max drawdown, 1 year | -54.0% | -29.0% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Sell | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
